Explore the innovative subcutaneous delivery of isatuximab for multiple myeloma, enhancing patient experience and treatment ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

Help is now there for those diagnosed with hard-to-treat blood cancers like leukemia and lymphoma, as new therapies are ...

Urvi A. Shah, MD, MS, embarked on a non-conventional career path when she developed a professional interest in researching ...

Discover why Genmab A/S stands out as a high-margin biotech with strong partnerships, robust growth prospects, and ...

Understand the importance of analyzing all cell populations within a sample to avoid incomplete assessments and ensure accurate Minimal Residual Disease (MRD) analysis in Multiple Myeloma (MM).

Through the Sarah Cannon Transplant & Cellular Therapy Program, patients will no longer have to travel out of state to receive treatment and, most importantly, go home at the end of the day.

The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...

During a live event, Jeffrey V. Matous, MD, discussed flexible dosing and the need to expand use in community practices for ...